EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Asymmetric Dimethylarginine and Its Relation as a Biomarker in Nephrologic Diseases

Mustafa E Sitar

Biomarker Insights · 2016-01 · 11 · BMI.S38434

DOI: 10.4137/bmi.s38434 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomarker Insights, online erschienen am 07.12.2016. Verfasst von Mustafa E Sitar. Beteiligte Einrichtung: Faculty of Medicine, Department of Clinical Biochemistry, Maltepe University, Maltepe, Istanbul, Republic of Turkey. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is encouraging to observe that a search for publications on “asymmetric dimethylarginine (ADMA)” in PubMed, as updated on June 2016, yielded >2500 items, 24 years after a splendid paper published by Vallance et al in which the authors proposed that ADMA accumulation could be a cardiovascular risk factor in chronic kidney diseases. ADMA is the endogenous inhibitor of nitric oxide synthase and is related to endothelial dysfunction, which plays an important role in vascular damage elicited by various cardiometabolic risk factors. Although current knowledge suggests that ADMA has critical central roles in renal diseases, there are still unexplained details. The present article aims to provide a review on ADMA and its relation as a biomarker in nephrologic diseases. We aimed to systematize articles in which ADMA levels were assessed in order to clarify its role in many diseases and establish its reference values in different populations.

Schlagwörter

Stichwörter der Autor:innen

asymmetric dimethylargininebiomarkerendothelial dysfunctionnitric oxideoxidative stressrenal failure

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Clinical Biochemistry, Maltepe University, Maltepe, Istanbul, Republic of Turkey.

Zitieren

APA

Sitar, M. E. (2016). Asymmetric Dimethylarginine and Its Relation as a Biomarker in Nephrologic Diseases. Biomarker Insights, 11, BMI.S38434. https://doi.org/10.4137/bmi.s38434

Vancouver

Sitar ME. Asymmetric Dimethylarginine and Its Relation as a Biomarker in Nephrologic Diseases. Biomarker Insights. 2016;11:BMI.S38434. doi:10.4137/bmi.s38434

BibTeX
@article{Sitar2016,
  author = {Sitar, Mustafa E},
  title = {Asymmetric Dimethylarginine and Its Relation as a Biomarker in Nephrologic Diseases},
  journal = {Biomarker Insights},
  year = {2016},
  volume = {11},
  pages = {BMI.S38434},
  doi = {10.4137/bmi.s38434}
}
Kostenlos starten →